The information highlighted (if any) are the most recent updates for this brand.
Patients should be closely monitored for any anginal symptoms (e.g., chest pain), since treatment with cilostazol may increase pulse rate, which could induce angina pectoris. [A significant increase in PRP (pressure rate product) was observed during long-term administration of cilostazol in a clinical trial to evaluate the drug's efficacy in the prevention of recurrence of cerebral infarction. Also, angina pectoris was observed in some of the patients treated with cilostazol.] (See Careful Administration and Important Precautions under Precautions and Clinically significant adverse reactions: Congestive heart failure, myocardial infarction, angina pectoris, and ventricular tachycardia under Adverse Reactions.)
Sign Out
